首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1544198

臨床試驗用品市場規模、佔有率和成長分析：按階段、最終用戶、服務、地區 - 產業預測，2024-2031 年

Clinical Trial Supplies Market Size, Share, Growth Analysis, By Phase, By End-user (Pharmaceutical and Biotechnology Companies, Contract Research Organisations ), By Service, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月27日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球臨床試驗用品市場規模為21億美元，從2023年的29億美元增至2031年的45億美元，預計在預測期內（2024-2031年）複合年成長率為6.5%。

由於全球化程度的提高、臨床試驗數量的增加以及對生技藥品和生物相似藥的日益關注等幾個關鍵因素，全球臨床試驗用品市場正在經歷顯著成長。為了控制高昂的研發成本並提高業務效率，生物製藥公司擴大採用先進的供應鏈管理系統。臨床試驗用品佔整體研發支出的很大一部分，隨著生技藥品和溫度敏感藥物試驗數量的增加，對專用臨床試驗設施的需求正在迅速增加。目前，38%的藥物需要溫度控制，35%的後期藥物是生物製藥，生物製劑因其比傳統藥物副作用更少而受到青睞。已開發和發展中地區對生物相似藥的需求不斷增加，進一步推動了市場發展。發展中國家具有成本優勢且易於招募患者，使其成為臨床試驗的一個有吸引力的地點。亞太地區、拉丁美洲以及中歐和東歐等地區具有經濟優勢且易於招募病患。例如，在新加坡和中國，政府正在投資生物醫學研究，而在拉丁美洲，語言障礙不是問題。此外，由於發展中國家的疾病種類繁多，我們可以支持罕見疾病的臨床試驗。這些綜合因素促進了臨床試驗用品市場的穩定擴張。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Catalent, Inc.（US）
Thermo Fisher Scientific Inc.（US）
Sharp Packaging Services（US）
CordenPharma（Austria）
Almac Group（UK）
PCI Pharma Services（US）
Eurofins Scientific（Luxembourg）
ICON plc（Ireland）
Biocair International Ltd（UK）
DHL（Germany）
Myoderm（US）
Ancillare LP（US）
Intertek Group plc（UK）
KLIFO A/S（Denmark）
N-SIDE（Belgium）
Sharp Clinical Services（US）
Catalent Pharma Solutions（US）
Woodfield Distribution, LLC（US）
Avantor, Inc.（US）
Worldwide Clinical Trials, Inc.（US）

簡介目錄

Product Code: SQMIG35D2077

Global Clinical Trial Supplies Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.9 billion in 2023 to USD 4.50 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global clinical trial supplies market has experienced substantial growth, driven by several key factors including increased globalization, a rise in the number of clinical trials, and a growing focus on biologics and biosimilars. To manage high research and development (R&D) costs and enhance operational efficiency, biopharmaceutical companies are increasingly adopting advanced supply chain management systems. Clinical trial supplies represent a significant portion of overall R&D expenditures, and with the rising number of biologics and temperature-sensitive drugs being tested, the demand for specialized clinical trial facilities has surged. Presently, 38% of pharmaceutical drugs require temperature control, and 35% of late-phase drugs are biologics, which are preferred for their reduced side effects compared to traditional medications. The market growth is further fueled by the increasing demand for biosimilars across both developed and developing regions. Developing countries offer cost advantages and facilitate patient recruitment, making them attractive locations for clinical trials. Regions such as Asia Pacific, Latin America, Central & Eastern Europe, and the Middle East provide economic benefits and ease of patient recruitment. For instance, governments in Singapore and China invest in biomedical research, while in Latin America, language barriers are less of an issue. Additionally, the diverse range of diseases in developing countries supports clinical trials for rare conditions. This combination of factors is contributing to the robust expansion of the clinical trial supplies market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Supplies Market Segmental Analysis

The Global Clinical Trial Supplies market is segmented by phase, application, therapeutic use, type, end user, service and region. Based on phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV. Based on application, the market is segmented into pharmaceutical and biopharmaceutical, and contract research organizations (CROs). Based on therapeutic use, market is segmented into Oncology, immunology, cardiology, genetic diseases, Cardiovascular, Infectious disease, Metabolic disorders, Others. Based on service market is segmented into Manufacturing, Storage & retention, logistics and distribution, packaging, labelling and blinding, comparator sourcing and others. Based on type market is segmented into, Small molecules, biological drugs, medical devices.Based on end-user, it is segmented as Pharmaceutical and Biotechnology Companies, Contract Research Organisations (CRO's), Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Clinical Trial Supplies Market

A major driver of the global clinical trial supplies market is the growing demand for specialized drug products, particularly biologics. Biologics are intricate molecules derived from living organisms and used to treat a range of diseases. Due to their complexity, these drugs necessitate specific clinical trial supplies to ensure their safety, efficacy, and stability throughout the research process. Essential supplies for biologics include specialized refrigeration, custom packaging materials, and advanced temperature monitoring systems to maintain their stability during trials. The rising demand for biologics, attributed to their effectiveness and fewer side effects compared to traditional treatments, is significantly fueling the need for these specialized clinical trial supplies.

Restraints in the Global Clinical Trial Supplies Market

A significant challenge for the global clinical trial supplies market is the rising cost of conducting clinical trials. These expenses have surged in recent years, constraining market growth. Furthermore, the complexities of patient recruitment and the stringent regulatory requirements associated with clinical trials further impede market expansion. These factors create barriers for small and mid-sized companies, making it challenging for them to enter and compete in the market. Consequently, the high costs and regulatory hurdles are limiting the overall growth and development of the clinical trial supplies sector.

Market Trends of the Global Clinical Trial Supplies Market

A notable trend in the global clinical trial supplies market is the increasing integration of blockchain technology. Blockchain provides a decentralized, secure, and transparent framework for tracking and managing the clinical trial supply chain, from production through to patient delivery. By offering real-time tracking, blockchain enhances the efficiency of clinical trials, minimizes errors and discrepancies, and strengthens data security. This technology is anticipated to play a growing role in the clinical trial supplies sector, driven by its potential to streamline operations and ensure greater integrity in the supply chain.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Degree Of Competition
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Pricing Analysis
Supply chain analysis
Patent analysis
Value chain analysis
Case study analysis

Clinical Trial Supplies Market by Service

Logistics & Distribution
Storage & Retention
Packaging, Labelling & Blinding
Manufacturing
Comparator Sourcing
Other Services
- Solutions
- Ancillary supplies

Clinical Trial Supplies Market by Phase

Phase I
Phase II
Phase III
Phase IV
BA/BE Studies

Clinical Trial Supplies Market by Type

Small-Molecules
Biologic Drugs
Medical Devices

Clinical Trial Supplies Market by Therapeutic Area

Oncology
Infectious Diseases
Neurology
Metabolic Disorders
Immunology
Cardiology
Genetic Diseases
Other Therapeutic Areas
- Respiratory Diseases
- Dermatological Conditions
- Rare Diseases
- ENT Diseases
- Nephrology

Clinical Trial Supplies Market by End-user

Pharmaceutical and Biotechnology Companies
Contract Research Organisations (CRO's)
Medical Device Companies

Clinical Trial Supplies Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Catalent, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Packaging Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CordenPharma (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PCI Pharma Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocair International Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DHL (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myoderm (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ancillare LP (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KLIFO A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
N-SIDE (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sharp Clinical Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent Pharma Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Woodfield Distribution, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worldwide Clinical Trials, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments